Elsayed Balbaa: Baseline Anemia Predicts Adverse 12-Month Outcomes After Elective PCI for Stable CAD
Elsayed Balbaa, Student of Alexandria University, shared a post on LinkedIn:
“A new Publication!
We found that in men undergoing first-time elective PCI for stable CAD, baseline anemia was associated with higher 12-month risks of AKI, major bleeding, need for transfusion, hospitalization, and death, especially with recent (≤ 1 year) bleeding or transfusion history.”
Mohamed R. Murad, Bachelor of Medicine, Bachelor of Surgery – MBBS at Al-Azhar University, shared a post on LinkedIn:
“Pleased to share our recent publication:
‘Prognostic Impact of Baseline Anemia on Outcomes After Elective PCI in Men: A US Retrospective Cohort Study.’
In this study, we examined the prognostic impact of baseline anemia on outcomes after elective PCI in men with stable coronary artery disease.
Our analysis incorporated survival analysis, Kaplan-Meier curves, log-rank testing, univariable and multivariable Cox proportional hazards regression, propensity score matching, falsification (negative-control) endpoint analysis, E-value sensitivity analysis, and multiple-testing adjustment using Benjamini-Hochberg and Bonferroni methods.
I’m truly happy to be part of this great work with such outstanding leaders, collaborators, and team members.
I’m deeply grateful for the guidance, dedication, and shared effort of all co-authors who contributed to this study.
Proud to contribute to research that advances clinical understanding and supports better patient care.”
Title: Catheterization and Cardiovascular Interventions
Authors: Abdalhakim Shubietah, Mohamed S. Elgendy, Mohamed Saad Rakab, Ahmed Ahmed, Batoul Abusalah, Mohamed R. Murad, Belal Mohamed Hamed, Hamza A. Abdul-Hafez, Ahmed Emara, Qutaiba Qafisheh, Elsayed Balbaa, Ameer Awashra, Ahmed Mansour, Ahmed Elbataa, Abdalrahman Assaassa, Mohammed Mhanna
Read the Article on Catheterization and Cardiovascular Interventions
Stay updated on all scientific advances with Hemostasis Today.
-
Jun 10, 2026, 18:22Winai Porntipworawech: The $50 Life-Saving Drug Big Pharma Doesn’t Want You to See
-
Jun 10, 2026, 18:09Leonard Valentino: Innovation in Blood Disorders Being Catalyzed by Pathway to Cures
-
Jun 10, 2026, 18:00Smitirupa Mishra: Normal Hemoglobin Does Not Always Mean Normal Genes
-
Jun 10, 2026, 17:58Talat Uppal: Addressing HMB with RACGP’s Dr. Ramya Raman
-
Jun 10, 2026, 17:52Throw Back Thursday to Past Bruises Posted in the Glanzmann’s Research Foundation
-
Jun 10, 2026, 17:52Priya Prasad: In Massive Hemorrhage, Fibrinogen Is Often the First Clotting Factor to Fall
-
Jun 10, 2026, 17:51Mariam Swidan: Some Red Blood Cells Can’t Handle Pressure
-
Jun 10, 2026, 17:49Ankit Mathur: Hosting ISBT Academy Day on Rare Donor Program in India
-
Jun 10, 2026, 17:48Shadi Tabibian: When Patients Bleed but Standard Testing Is Normal